Share this article

Facebook
Twitter
Print
Email

USFDA Completes inspection of Biocon’s Bengaluru plant; No faults found

Biocon-arm-Syngene-expands-RD-with-Baxter-Health-Corp

The US Food & Drug Administration said on Monday it has completed pre-approval inspection of Biocon’s new oral solid dosage facility in Bengaluru.

The drug regulator audited the plant from November 5 to November 9, 2018.

“The audit concluded without any observations and Form 483 was issued.” Biocon said in a statement to the stock exchanges. “The successful audit of this site reflects our strong commitment to quality and cGMP compliance,” it added.

The USFDA inspection was triggered after Biocon filed for an abbreviated new drug application (ANDA) or product approval in the US. The company didn’t disclose details of the product.
Biocon largely focuses on cholesterol lowering statins, immunosuppressants and cancer drugs as part of its oral solid formulation business.

RECENT NEWS

Jet Airways Chairman Naresh Goyal to Invest Up to Rs 700 Crore in Jet Airways

Jet Airways chairman Naresh Goyal is ready to invest up to Rs 700 crore in Jet Airways on the condition that his stake does not fall below 25%. Goyal’s offer comes against the backdrop of strategic partner Etihad reportedly putting forward strict conditions, including that Goyal should give up control, for infusing funds into the crisis-hit carrier.

Bihar CM Nitish Kumar Ready to Reconcile with RJD

Bihar Chief Minister Nitish Kumar on Tuesday night claimed that he has “lots of love” for Rashtriya Janata Dal (RJD) leader Tejashwi Yadav despite the “harsh words” the latter often uses.

PM Modi Lashes Out At Kerala Government for Sabarimala Mismanagement

In Kollam today for the launch of two projects, PM Modi said: “The CPM government’s conduct on Sabarimala will go down in history as the most shameful action of any government in power… We know CPM government never respected spirituality, religion… but no one thought it would turn so shameful”.

Spat Over Rafale Is On High Gear

In its response to Pune-based activist Vihar Durve who had sought the report from CAG, the country’s auditor said, “The audit is under progress and the report is yet to be finalised. The information cannot be given under Section 8(1)(C) of the RTI Act as the disclosure would cause breach of Parliament”.